ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,261Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 231

$660K Total Retail Price of All Prescriptions

Rank: 14 out of 231

486 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 486 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 486 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 10,676 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
INSULIN SYRINGE 630 601 10 1 43
FUROSEMIDE 389 362 2 6
WARFARIN SODIUM 343 299 3 17
OMEPRAZOLE 333 282 4 5
AMLODIPINE BESYLATE 318 301 5 4
POTASSIUM CHLORIDE 309 287 6 33
LISINOPRIL 285 276 7 1
SYNTHROID 271 251 8 28
SIMVASTATIN 231 229 9 2
METOPROLOL TARTRATE 227 227 10 12
GABAPENTIN 212 186 11 15
QUETIAPINE FUMARATE 211 205 12 39
LACTULOSE 210 146 13 84
MIRTAZAPINE 205 205 14 25
LANTUS 196 185 15 42
METFORMIN HCL 163 151 16 7
SERTRALINE HCL 158 141 17 18
CITALOPRAM HBR 152 134 18 20
NOVOLOG 152 136 18 72
LEVOTHYROXINE SODIUM 147 142 20 3
PLAVIX 140 134 21 60
SEROQUEL 138 133 22 83
DONEPEZIL HCL 138 134 22 26
HYDROCHLOROTHIAZIDE 132 115 24 9
LEVETIRACETAM 130 87 25 57
DIVALPROEX SODIUM 119 113 26 53
METOPROLOL SUCCINATE 118 118 27 13
ATENOLOL 116 116 28 11
TRAMADOL HCL 116 102 28 16
DIGOXIN 113 107 30 80
RISPERIDONE 106 80 31 34
CYMBALTA 105 92 32 46
TRAZODONE HCL 102 98 33 35
IPRATROPIUM-ALBUTEROL 99 97 34 68
ISOSORBIDE MONONITRATE ER 99 99 34 56
CLOPIDOGREL 97 95 36 44
NAMENDA 97 97 36 47
DIOVAN 94 81 38 27
FLUOXETINE HCL 89 66 39 67
CARBAMAZEPINE 85 66 40 150
CARVEDILOL 82 81 41 24
PREDNISONE 82 75 41 41
SULFAMETHOXAZOLE-TRIMETHOPRIM 75 61 43 77
CLONIDINE HCL 75 61 43 63
AMOX TR-POTASSIUM CLAVULANATE 74 62 45 81
ESCITALOPRAM OXALATE 71 59 46 55
CIPROFLOXACIN HCL 68 60 47 58
CHLORHEXIDINE GLUCONATE 66 33 48 163
TAMSULOSIN HCL 66 48 48 30
AZITHROMYCIN 66 62 48 32
CARBIDOPA-LEVODOPA 65 65 51 73
FENTANYL 62 32 S2 52 69
GLIPIZIDE 62 62 52 71
NITROFURANTOIN MONO-MACRO 61 59 54 76
ADVAIR DISKUS 60 42 55 50
VALPROIC ACID 60 21 55 133
SUBOXONE 58 31 57 147
ATORVASTATIN CALCIUM 58 49 57 8
LOSARTAN POTASSIUM 57 53 59 29
BACLOFEN 54 19 60 89
LATANOPROST 54 47 60 107
ALENDRONATE SODIUM 53 47 62 45
CEPHALEXIN 52 43 63 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.